Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
Crossref DOI link: https://doi.org/10.1007/s12325-021-01994-2
Published Online: 2021-11-30
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mende, Christian W.
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2021-11-30
Version of Record valid from 2021-11-30
Article History
Received: 18 October 2021
Accepted: 10 November 2021
First Online: 30 November 2021